Clinical efficacy of 300IR five-grass pollen sublingual tablet by baseline timothy-specific serum IgE in a US study

被引：0
|
作者：
Cox, L. [1 ]
Casale, T. [2 ]
Creticos, P. [3 ]
Ambroisine, L. [4 ]
Le Gall, M. [4 ]
Melac, M. [4 ]
Zeldin, R. [4 ]
机构：
[1] Nova SE Univ, Sch Osteopath Med, Davie, FL USA
[2] Creighton Univ Allergy & Asthma, Dept Med, Div Allergy & Immunol, Omaha, NE USA
[3] Johns Hopkins Univ, Baltimore, MD USA
[4] Stallergenes, Antony, France
来源：
ALLERGY | 2012年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
1101
引用
收藏
页码：419 / 420
页数：2
相关论文
共 50 条
  • [31] Efficacy of 300IR 5-grass pollen sublingual tablets in the treatment of conjunctivitis symptoms in patients with grass pollen-induced allergic rhinoconjunctivitis
    Paolozzi, L.
    Tabar, A., I
    Valle, C.
    Soulie, S.
    Zeldin, R. K.
    ALLERGY, 2014, 69 : 612 - 613
  • [32] Efficacy Of 300IR 5-Grass Pollen Sublingual Tablets In The Treatment Of Rhinitis Symptoms In Patients With Grass Pollen-Induced Allergic Rhinoconjunctivitis
    Bachert, Claus
    Didier, Alain
    Ambroisine, Laurence
    Abiteboul, Kathy
    Zeldin, Robert K.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (02) : AB219 - AB219
  • [33] Long-Term Treatment with 300IR 5-Grass Pollen Sublingual Tablet in Grass Pollen Allergic Subjects: Safety Outcome Year after Year
    Golden, David B. K.
    Fahrenholz, John M.
    Renahan, Kevin E.
    Khairallah, Sandrine
    Abiteboul, Kathy
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB60 - AB60
  • [34] Long-term Safety Of A 300IR Sublingual Tablet Of 5-grass-pollen Allergen Extract In Adults With Grass-pollen-induced Allergic Rhinoconjunctivitis
    Didier, A.
    Worm, M.
    Horak, F.
    Malling, H.
    Montagut, A.
    Zeldin, R. K.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB248 - AB248
  • [35] Sublingual Immunotherapy with a Five-Grass Pollen Tablet in Adult Patients with Allergic Rhinitis: An Open, Prospective, Noninterventional, Multicenter Study
    Pfaar, Oliver
    Richter, Heinz-Gerd
    Klimek, Ludger
    Sieber, Jochen
    Hadler, Meike
    Karagiannis, Efstrathios
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [36] Efficacy and safety of 300IR 5-grass pollen sublingual allergen immunotherapy tablets in adult patients with grass-pollen rhinoconjunctivitis in United States
    Cox, L.
    Casale, T.
    Nayak, A.
    Bernstein, D.
    Mekhaldi, S.
    de Beaumont, O.
    Melac, M.
    Montagut, A.
    Creticos, P.
    ALLERGY, 2011, 66 : 63 - 63
  • [37] Treatment effect of 300IR 5-grass pollen tablet for pre-coseasonal sublingual immunotherapy of grass pollen-induced allergic rhinoconjunctivitis: Clinical impact from the patient perspective
    Brehler, R.
    Pfaar, O.
    Canonica, G. W.
    Devillier, P.
    Demoly, P.
    Scurati, S.
    Dolimier, E.
    ALLERGY, 2023, 78
  • [38] Treatment Satisfaction During Sublingual Immunotherapy with a Five-Grass Pollen Tablet for Allergic Rhinoconjunctivitis: A Prospective, Non-Interventional Study
    Schäfer U.
    Kienle-Gogolok A.
    Hadler M.
    Karagiannis E.
    Schnitzer S.
    Drugs - Real World Outcomes, 2017, 4 (2) : 109 - 117
  • [39] Relationship between allergic disease severity and efficacy of 300IR 5-grass pollen SLIT tablets for sublingual immunotherapy
    Didier, A.
    Horak, F.
    Worm, M.
    Melac, M.
    de Beaumont, O.
    Le Gall, M.
    Montagut, A.
    Rodriguez, P.
    Malling, A.
    ALLERGY, 2011, 66 : 137 - 138
  • [40] Consistency of short- and long- term clinical trials results with 300 IR five-grass pollen tablets
    Bachert, C.
    Didier, A.
    Wahn, U.
    Le Gall, M.
    de Beau-Mont, O.
    Melac, M.
    Montagut, A.
    Malling, H.
    ALLERGY, 2011, 66 : 137 - 137
12345